BMP2 and Osteopenia: The present study shows that combined delivery of HA and low-dose BMP-2 (1 μg) or GDF-5 (5 μg) is highly suitable for the therapy of lumbar osteopenia in aged sheep [40], including long-term augmentation of bone structure and bone formation, as well as biomechanical stabilization.